Anny OrtizJan 24, 20238 min readPharmaceutical InequalitiesA brief review of psychedelics’ biological and psychological mechanisms
Gabriel Lake CarterJan 12, 20233 min readPharmaceutical InequalitiesDiscussions on Enacting Transdisciplinarity in Psychedelic Studies
Gabriel Lake CarterJan 5, 20233 min readPharmaceutical InequalitiesFuture Histories of Psychedelic Biomedicine
Gabriel Lake CarterDec 15, 20223 min readPharmaceutical InequalitiesMosaics of Support for Psychedelic Risk Reduction
Anny OrtizDec 6, 20228 min readPharmaceutical InequalitiesReflections on how the Yaqui Intercultural Medicine Clinic came to be
Amanda PrattDec 1, 20229 min readFrom the CollectionsPoints Interview: Philipp Rühr, Archival Researcher Network participant.
Gabriel Lake CarterNov 24, 20222 min readConferences and EventsPlants as Psychoactives and Medicines: Touring Allen Centennial Gardens
Gabriel Lake CarterNov 1, 20226 min readPharmaceutical InequalitiesTransdisciplinarity to Address Inequality in Psychedelic Studies
Points EditorsOct 25, 20222 min readConferences and EventsTransdisciplinary Approaches for Psychedelic Experiences Lecture
Anny OrtizOct 18, 20225 min readPharmaceutical InequalitiesThe toad boom: the false narrative of ancestral 5-MeO-DMT use
Points EditorsSep 23, 20221 min readConferences and EventsPsychedelic Pasts, Presents & Futures Roundtable
Amanda PrattAug 2, 20222 min readPharmaceutical InequalitiesRight Wing Psychedelia with Dr. Brian Pace and Dr. Neşe Devenot
Anny OrtizMay 31, 20228 min readPharmaceutical InequalitiesThe emerging therapeutic value of 5-MeO-DMT
Points EditorsMay 26, 20223 min readCalls for PapersCFP: Psychedelic Capitalism: From Forest Retreat to Fortune 500 and Pharmacies
Anny OrtizMay 10, 20228 min readPharmaceutical InequalitiesPsychedelics in the treatment of substance use disorders: the case of ibogaine
